微信公众号
证券之星APP
| 报告期 | 销售毛利率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | 71% | -8.56% | -4.73% | 19/131 | 51.25% | 佰仁医疗 | 85.72% | 行业排名> |
| 2024-12-31 | 74.53% | 1.8% | -2.04% | 13/131 | 52.33% | 佰仁医疗 | 88.34% | 行业排名> |
| 2024-09-30 | 76.08% | 1.39% | 1.29% | 14/131 | 53.43% | 佰仁医疗 | 88.56% | 行业排名> |
| 2024-06-30 | 75.11% | 3.9% | -3.26% | 16/131 | 53.5% | 佰仁医疗 | 89.27% | 行业排名> |
| 2024-03-31 | 77.65% | 18.13% | 6.06% | 13/131 | 53.43% | 佰仁医疗 | 89.28% | 行业排名> |
| 2023-12-31 | 73.21% | 20.41% | -2.43% | 18/131 | 53.31% | 正海生物 | 89.9% | 行业排名> |
| 2023-09-30 | 75.04% | 23.36% | 3.79% | 17/131 | 54.06% | 正海生物 | 90.39% | 行业排名> |
| 2023-06-30 | 72.29% | 19.55% | 9.98% | 18/131 | 53.45% | 正海生物 | 90.3% | 行业排名> |
| 2023-03-31 | 65.73% | -11.62% | 8.11% | 41/131 | 53.66% | 正海生物 | 89.78% | 行业排名> |
| 2022-12-31 | 60.8% | -16.84% | -0.04% | 51/131 | 53.83% | 三友医疗 | 90.18% | 行业排名> |
| 2022-09-30 | 60.83% | -22.82% | 0.58% | 49/131 | 55.13% | 三友医疗 | 90.14% | 行业排名> |
| 2022-06-30 | 60.47% | -24.65% | -18.69% | 55/131 | 54.78% | 三友医疗 | 90.29% | 行业排名> |
| 2022-03-31 | 74.37% | -8.44% | 1.73% | 21/131 | 56.28% | 三友医疗 | 90.73% | 行业排名> |
| 2021-12-31 | 73.11% | 1.76% | -7.24% | 26/131 | 57.29% | 三友医疗 | 90.5% | 行业排名> |
| 2021-09-30 | 78.81% | 2% | -1.8% | 13/131 | 59.17% | 三友医疗 | 90.29% | 行业排名> |
| 2021-06-30 | 80.26% | 21.54% | -1.19% | 12/131 | 58.42% | 正海生物 | 90.78% | 行业排名> |
| 2021-03-31 | 81.22% | 2% | 13.06% | 11/131 | 60.75% | 正海生物 | 91.59% | 行业排名> |
| 2020-12-31 | 71.84% | -10.85% | 8.8% | 40/131 | 59.59% | 正海生物 | 92.23% | 行业排名> |
| 2020-06-30 | 66.03% | 2% | -18.05% | 40/131 | 59.94% | 正海生物 | 92.69% | 行业排名> |
| 2019-12-31 | 80.58% | 5.46% | 5.46% | 17/131 | 56.37% | 正海生物 | 92.61% | 行业排名> |
| 2018-12-31 | 76.41% | 5.24% | 5.24% | 26/131 | 55.53% | 正海生物 | 94.38% | 行业排名> |
| 2017-12-31 | 72.61% | 2% | 2% | 27/131 | 55.34% | 正海生物 | 93.12% | 行业排名> |